Global Sepsis Diagnostics
Market is expected to grow at a significant CAGR in the upcoming years as the
scope and its applications are increasing across the globe. Sepsis also known
as septicaemia is a severe illness triggered by the body’s response to an
infection. Lungs, pelvis, abdomen and urinary tract are some of the most common
places of infection giving rise to sepsis. The people who are at a risk for
sepsis include geriatric population, individual exposed to invasive device,
weaker immune system such as cancer patients, HIV, etc. Some of the symptoms of
sepsis include dizziness, nausea & vomiting, high fever, rapid heart rate,
chills & shivering, confusion and disorientation, rapid breathing, etc.
Browse Full Report With TOC @ https://www.millioninsights.com/industry-reports/sepsis-diagnostics-market
The factors that propel the
growth of the Sepsis Diagnostics Market include rise in geriatric population,
prevalence of hospital-acquired infections, considerable rise in surgical
procedures and increasing innovations & approvals of products. On the other
hand, there are also factors that may hamper the growth of the market such as
dearth of skilled labour and absence of standard protocols. Sepsis Diagnostics Market is classified on
the basis of product, method, technology, usability, pathogen and geography.
Sepsis Diagnostics Market is classified on the basis of product as assays &
reagents, blood culture media, instruments, software and others. Among the
product, blood culture media is estimated to hold a dominant share of the
Sepsis Diagnostics Market in 2016.
Sepsis Diagnostics Market is
classified on the basis of method as conventional diagnostics and automated
diagnostics. Sepsis Diagnostics Market is classified on the basis of technology
as microbiology, molecular diagnostics, flow cytometry, immunoassays and
others. Sepsis Diagnostics Market is classified on the basis of usability as
laboratory testing, point-of-care testing and others. Sepsis Diagnostics Market
is classified on the basis of pathogen as fungal sepsis, bacterial sepsis, and
others (viral and parasitic infection). The bacterial sepsis consists of
Gram-negative bacterial sepsis, Gram-positive bacterial sepsis.
Among the pathogen, bacterial
sepsis is projected to account a major share of the Sepsis Diagnostics Industry
in 2016. Sepsis Diagnostics Industry is classified on the basis of geography as
North America, Latin America, Western Europe, Eastern Europe, Asia Pacific,
Japan and Middle East and Africa. The
North American region consists of the U.S., and Canada. Latin America region
consists of Mexico and Brazil. The Western European region consists of Germany,
Italy, France, England and Spain. The Eastern European region consists of
Poland and Russia. Asia Pacific region consists of China, India, ASEAN,
Australia & New Zealand. The Middle East and Africa region consists of GCC,
South Africa and North Africa.
In case of geographical
region, North America is projected to hold a dominant share of the Global
Sepsis Diagnostics Industry. However, Asia Pacific is expected to account a
significant share in the Global Sepsis Diagnostics Industry. The key factors
that contribute to the growth of this region is owed to evolving healthcare
infrastructure & facilities, growing number of surgical procedures and
rising number of clinical studies. Some
of the key players that fuel the growth of the Sepsis Diagnostics Industry
include Abbott Laboratories, Inc., bioMérieux SA, Becton, Cepheid, Dickinson
and Company, Nanosphere, Inc., T2 Biosystems, Inc., Thermo Fisher Scientific
Inc., Roche Diagnostics Limited, Bruker Corporation and Beckman Coulter, Inc.
View Sample Copy Of this Report @ https://www.millioninsights.com/industry-reports/sepsis-diagnostics-market/request-sample
No comments:
Post a Comment